Skip to main content
Top
Published in: Acta Diabetologica 8/2018

Open Access 01-08-2018 | Original Article

Influence of early-life parental severe life events on the risk of type 1 diabetes in children: the DiPiS study

Authors: Markus Lundgren, Katarina Ellström, Helena Elding Larsson, for the DiPiS study group

Published in: Acta Diabetologica | Issue 8/2018

Login to get access

Abstract

Aims

Stress and severe life events (SLEs) modify autoimmune disease susceptibility. Here, we aimed to establish if SLEs reported by parents during the first 2 years of life influence the risk of developing type 1 diabetes (T1D) using data from the prospective Diabetes Prediction in Skåne (DiPiS) study.

Methods

Prospective questionnaire data recorded at 2 months (n = 23,187) and 2 years of age (n = 3784) from the DiPiS cohort of children were included in the analysis. SLEs were analyzed both by groups and as a combined variable. A Cox proportional hazards model was used to calculate hazard ratios (HRs) for T1D diagnosis for the total cohort and for the HLA-DQ2/8 high-risk population. Affected first-degree relatives, HLA-DQ risk group, paternal education level, and parents’ country of birth were included as covariates.

Results

There was a significantly increased risk of T1D in children with SLEs occurring during the child’s first 2 years of life for both the total cohort (HR 1.67; 95% CI 1.1, 2.7; p = 0.03) and the DQ2/8 cohort (HR 2.2; 95% CI 1.1, 4.2; p = 0.018). Subgroup analysis of events related to unemployment, divorce, or family conflict showed a significant hazard for these events occurring both during and after pregnancy in the DQ2/8 cohort (HR 2.17; 95% CI 1.1, 4.3; p = 0.03 and HR 4.98; 95% CI 2.3, 11; p < 0.001, respectively) and after pregnancy in the total cohort (multiple regression HR 2.07; 95% CI 1.01, 4.2; p = 0.047).

Conclusions

Children of parents experiencing an SLE during the child’s first 2 years of life were at increased risk of T1D. Further studies including those measuring immune and stress-related biomarkers are necessary to validate the findings.
Literature
8.
go back to reference Miller GE, Cohen S, Ritchey AK (2002) Chronic psychological stress and the regulation of pro-inflammatory cytokines: a glucocorticoid-resistance model. Health Psychol 21:531–541CrossRefPubMed Miller GE, Cohen S, Ritchey AK (2002) Chronic psychological stress and the regulation of pro-inflammatory cytokines: a glucocorticoid-resistance model. Health Psychol 21:531–541CrossRefPubMed
9.
go back to reference Faresjo M (2015) The link between psychological stress and autoimmune response in children. Crit Rev Immunol 35:117–134CrossRefPubMed Faresjo M (2015) The link between psychological stress and autoimmune response in children. Crit Rev Immunol 35:117–134CrossRefPubMed
10.
go back to reference Sepa A, Wahlberg J, Vaarala O et al (2005) Psychological stress may induce diabetes-related autoimmunity in infancy. Diabetes Care 28:290–295CrossRefPubMed Sepa A, Wahlberg J, Vaarala O et al (2005) Psychological stress may induce diabetes-related autoimmunity in infancy. Diabetes Care 28:290–295CrossRefPubMed
13.
go back to reference Cosgrove M (2004) Do stressful life events cause type 1 diabetes? Occup Med (Lond) 54:250–254CrossRef Cosgrove M (2004) Do stressful life events cause type 1 diabetes? Occup Med (Lond) 54:250–254CrossRef
15.
go back to reference Littorin B, Sundkvist G, Nyström L et al (2001) Family characteristics and life events before the onset of autoimmune type 1 diabetes in young adults: a nationwide study. Diabetes Care 24:1033–1037CrossRefPubMed Littorin B, Sundkvist G, Nyström L et al (2001) Family characteristics and life events before the onset of autoimmune type 1 diabetes in young adults: a nationwide study. Diabetes Care 24:1033–1037CrossRefPubMed
16.
go back to reference Coe CL, Lubach GR (2003) Critical periods of special health relevance for psychoneuroimmunology. Brain Behav Immun 17:3–12CrossRefPubMed Coe CL, Lubach GR (2003) Critical periods of special health relevance for psychoneuroimmunology. Brain Behav Immun 17:3–12CrossRefPubMed
18.
go back to reference The WHO QoL Working Group (1995) The World Health Organization Quality of Life assessment (WHOQOL): position paper from the World Health Organization. Soc Sci Med 41:1403–1409CrossRef The WHO QoL Working Group (1995) The World Health Organization Quality of Life assessment (WHOQOL): position paper from the World Health Organization. Soc Sci Med 41:1403–1409CrossRef
34.
go back to reference Sipetic S, Vlajinac H, Marinkovi J et al (2007) Stressful life events and psychological dysfunctions before the onset of type 1 diabetes mellitus. J Pediatr Endocrinol Metab 20:527–534CrossRefPubMed Sipetic S, Vlajinac H, Marinkovi J et al (2007) Stressful life events and psychological dysfunctions before the onset of type 1 diabetes mellitus. J Pediatr Endocrinol Metab 20:527–534CrossRefPubMed
36.
go back to reference Hägglöf B, Blom L, Dahlquist G et al (1991) The Swedish childhood diabetes study: indications of severe psychological stress as a risk factor for type 1 (insulin-dependent) diabetes mellitus in childhood. Diabetologia 34:579–583CrossRefPubMed Hägglöf B, Blom L, Dahlquist G et al (1991) The Swedish childhood diabetes study: indications of severe psychological stress as a risk factor for type 1 (insulin-dependent) diabetes mellitus in childhood. Diabetologia 34:579–583CrossRefPubMed
Metadata
Title
Influence of early-life parental severe life events on the risk of type 1 diabetes in children: the DiPiS study
Authors
Markus Lundgren
Katarina Ellström
Helena Elding Larsson
for the DiPiS study group
Publication date
01-08-2018
Publisher
Springer Milan
Published in
Acta Diabetologica / Issue 8/2018
Print ISSN: 0940-5429
Electronic ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-018-1150-y

Other articles of this Issue 8/2018

Acta Diabetologica 8/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.